TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

FOUGERA

CardiovascularNeurologyImmunology
Generics

FOUGERA is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology.

1997
Since
4
Drugs
-
Trials
13
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

NYSTATIN 2026-02-05
TIMOLOL MALEATE 2025-05-20
Labeling
TIMOLOL MALEATE 2025-05-20
Labeling
TIMOLOL MALEATE 2025-05-19
Labeling
TIMOLOL MALEATE 2025-05-16
Manufacturing (CMC)
NYSTATIN 2025-03-21
TIMOLOL MALEATE 2024-09-16
TIMOLOL MALEATE 2024-08-07
TIMOLOL MALEATE 2024-07-03
TIMOLOL MALEATE 2024-07-03
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 30%
1 drugs
Neurology 30%
1 drugs
Immunology 20%
0 drugs Phase 3: 1
Dermatology 20%
0 drugs Phase 3: 1

Pipeline Strength Pro

Loading...

Competitors Pro

PAI HOLDINGS PHARM big-pharma
Dermatology, Neurology, Cardiovascular, Immunology
Eli Lilly big-pharma
Immunology, Neurology, Dermatology
BAUSCH specialty
Dermatology, Immunology, Cardiovascular
ADVANZ PHARMA big-pharma
Immunology, Neurology, Cardiovascular, Dermatology
COSETTE other
Cardiovascular, Dermatology, Immunology